NovoCure Ltd (NVCR)
30.83
+0.43
(+1.41%)
USD |
NASDAQ |
Dec 20, 16:00
30.81
-0.02
(-0.06%)
After-Hours: 20:00
NovoCure Free Cash Flow: -78.21M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 6.486B |
| LeMaitre Vascular Inc | 33.49M |
| Insulet Corp | 218.20M |
| Globus Medical Inc | 293.77M |
| Perspective Therapeutics Inc | -40.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 10.38M |
| Cash from Investing (Quarterly) | 10.19M |
| Cash from Financing (Quarterly) | 0.10M |
| Free Cash Flow Per Share (Quarterly) | -0.0028 |
| Free Cash Flow to Equity (Quarterly) | -1.319M |
| Free Cash Flow to Firm (Quarterly) | -0.307M |
| Free Cash Flow Yield | -2.36% |